(Q26824439)

Amir-Abbas Kani

2

1 reference

Mohammad Mohammadianpanah

3

1 reference

Hamid Nasrolahi

4

1 reference

Shapour Omidvari

5

1 reference

Ahmad Mosalaei

6

1 reference

Mansour Ansari

7

1 reference

language of work or name

1 reference

March 2013

1 reference

Journal of the Egyptian National Cancer Institute

published in

1 reference

volume

25

1 reference

issue

1

1 reference

page(s)

21-30

1 reference

Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Therapeutic advances for glioblastoma multiforme: current status and future prospects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

A review of current and future treatment strategies for malignant astrocytomas in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

The 2007 WHO classification of tumours of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Management of glioblastoma multiforme in HIV patients: a case series and review of published studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Survival analysis of 205 patients with glioblastoma multiforme: clinical characteristics, treatment and prognosis in China

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Molecular advances of brain tumors in radiation oncology

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Glioblastoma multiforme-report of 267 cases treated at a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

The conditional probabilities of survival in patients with anaplastic astrocytoma or glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

The prognostic significance of midline shift at presentation on survival in patients with glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

A population-based study of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Novel anti-angiogenic therapies for malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Long-term survival with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Feasibility and toxicity of CCNU therapy in elderly patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: a retrospective analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

PCV chemotherapy for recurrent glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology).

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Glioblastoma multiforme: a review of where we have been and where we are going

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Antiangiogenic therapy in malignant glioma: promise and challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNCI.2012.11.001

7 January 2021

10.1016/J.JNCI.2012.11.001

Identifiers

DOI

0 references

PubMed publication ID

23499203

1 reference